CardioGenics Holdings Inc
CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market. Its products include QL Care Analyzer, which is a portable, stand-alone, and automated POC immunoanalyzer; a series of immunoassay tests to enhance the management of patients with cardiovascular diseases; and paramagnetic beads that are used as a sol… Read more
CardioGenics Holdings Inc (CGNH) - Total Liabilities
Latest total liabilities as of January 2016: $2.34 Million USD
Based on the latest financial reports, CardioGenics Holdings Inc (CGNH) has total liabilities worth $2.34 Million USD as of January 2016.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
CardioGenics Holdings Inc - Total Liabilities Trend (2000–2015)
This chart illustrates how CardioGenics Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
CardioGenics Holdings Inc Competitors by Total Liabilities
The table below lists competitors of CardioGenics Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Inbest Prime VII Inmuebles SOCIMI S.A.
MC:YINB7
|
Spain | €9.93K |
|
KUNLUN ENERGY
MU:CTJ1
|
Germany | €57.74 Billion |
|
QuantumKore Inc
PINK:SBOX
|
USA | $87.58K |
|
ITV - Dusseldorf Stock Exchang
DU:IJ7
|
Germany | €2.36 Billion |
|
Brera Holdings PLC
NASDAQ:SLMT
|
USA | $22.25 Million |
Liability Composition Analysis (2000–2015)
This chart breaks down CardioGenics Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.31 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 4.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CardioGenics Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CardioGenics Holdings Inc (2000–2015)
The table below shows the annual total liabilities of CardioGenics Holdings Inc from 2000 to 2015.
| Year | Total Liabilities | Change |
|---|---|---|
| 2015-10-31 | $1.79 Million | +25.96% |
| 2014-10-31 | $1.42 Million | -2.73% |
| 2013-10-31 | $1.46 Million | +64.83% |
| 2012-10-31 | $888.77K | +99.71% |
| 2011-10-31 | $445.04K | -23.29% |
| 2010-10-31 | $580.18K | -37.15% |
| 2009-10-31 | $923.14K | +170.75% |
| 2008-10-31 | $340.96K | -97.69% |
| 2007-10-31 | $14.77 Million | +191.16% |
| 2006-10-31 | $5.07 Million | +133.87% |
| 2005-10-31 | $2.17 Million | +1972.20% |
| 2004-10-31 | $104.70K | -82.53% |
| 2003-10-31 | $599.46K | -56.99% |
| 2002-10-31 | $1.39 Million | +214.03% |
| 2001-10-31 | $443.87K | -81.03% |
| 2000-10-31 | $2.34 Million | -- |